(Q24673149)

English

Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers (English)

0 references

0 references

1 reference

David E Martin

1

0 references

Robert Blum

series ordinal

2

0 references

John Wilton

series ordinal

3

0 references

Judy Doto

series ordinal

4

0 references

Hal Galbraith

series ordinal

5

0 references

Gina L Burgess

series ordinal

6

0 references

Philip C Smith

series ordinal

7

0 references

Charles Ballow

series ordinal

8

0 references

language of work or name

English

0 references

publication date

September 2007

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

51

0 references

issue

9

0 references

page(s)

3063-6

0 references

cites work

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043192

retrieved

7 April 2017

The prevalence of antiretroviral drug resistance in the United States

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043192

retrieved

28 September 2017

PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043192

retrieved

28 September 2017

HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043192

retrieved

28 September 2017

Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial).

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043192

retrieved

28 November 2018

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043192

28 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576843

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structural characterization of anti-HIV drug candidate PA-457 [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] and its acyl glucuronides in rat bile and evaluation of in vitro stability in human and animal liver microsomes and plasma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17576843

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stability of acyl glucuronides in blood, plasma, and urine: studies with zomepirac

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17576843

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

0 references

PubMed publication ID

17576843

0 references

(Q24673149)

Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)